Peter Rossing Selected Research

Peter Rossing Research Topics

Disease

134	Type 2 Diabetes Mellitus (MODY) 07/2022 - 03/2004
90	Albuminuria 06/2022 - 07/2002
89	Diabetic Nephropathies (Diabetic Nephropathy) 06/2022 - 07/2002
67	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2022 - 05/2002
67	Chronic Renal Insufficiency 06/2022 - 07/2008
44	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 10/2004
32	Heart Failure 01/2022 - 03/2012
27	Chronic Kidney Failure (Chronic Renal Failure) 10/2021 - 09/2004
23	Kidney Diseases (Kidney Disease) 04/2022 - 07/2009
23	Renal Insufficiency (Renal Failure) 03/2022 - 05/2019
22	Inflammation (Inflammations) 06/2022 - 12/2006
15	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 11/2010
13	Disease Progression 06/2022 - 07/2008
12	Hyperkalemia 04/2022 - 12/2005
12	Hypertension (High Blood Pressure) 01/2018 - 07/2009
11	Diabetes Mellitus 03/2022 - 01/2015
10	Stroke (Strokes) 01/2022 - 10/2012
9	Diabetes Complications 07/2022 - 03/2013
8	Body Weight (Weight, Body) 12/2021 - 01/2008
8	Proteinuria 01/2021 - 03/2004
7	Fibrosis (Cirrhosis) 04/2022 - 11/2010
7	Heart Diseases (Heart Disease) 01/2021 - 08/2011
6	Weight Loss (Weight Reduction) 12/2021 - 11/2015
6	Atherosclerosis 01/2021 - 08/2011
6	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 10/2004
5	Obesity 01/2022 - 03/2017
5	Infections 01/2021 - 12/2019
4	Myocardial Infarction 01/2022 - 12/2018
3	Hypoglycemia (Reactive Hypoglycemia) 07/2022 - 03/2011
3	Neoplasms (Cancer) 01/2021 - 01/2017
3	Insulin Resistance 01/2020 - 01/2017
2	Hypertrophy 03/2022 - 03/2012
2	Overweight 01/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

56	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2006
50	AlbuminsIBA 04/2022 - 05/2002
45	CreatinineIBA 04/2022 - 10/2004
26	dapagliflozinIBA 04/2022 - 01/2019
24	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 01/2009
20	Liraglutide FDA Link 01/2022 - 04/2015
19	finerenoneIBA 06/2022 - 01/2014
16	Mineralocorticoid Receptor AntagonistsIBA 04/2022 - 01/2014
16	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2022 - 12/2018
15	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 05/2002
15	Losartan (Cozaar)FDA LinkGeneric 01/2017 - 07/2002
13	SodiumIBA 03/2022 - 12/2018
13	Insulin (Novolin)FDA Link 01/2022 - 01/2008
12	Sodium-Glucose Transport ProteinsIBA 01/2022 - 12/2018
12	Irbesartan FDA LinkGeneric 01/2016 - 03/2004
11	pro-brain natriuretic peptide (1-76)IBA 09/2021 - 08/2011
11	CalciumIBA 01/2021 - 08/2011
10	Uric Acid (Urate)IBA 12/2021 - 07/2009
10	ProteomeIBA 01/2020 - 07/2008
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2010
9	Glucagon-Like Peptide 1 (GLP 1)IBA 08/2021 - 07/2015
9	CholesterolIBA 01/2021 - 03/2003
9	Angiotensin Receptor AntagonistsIBA 01/2019 - 07/2002
8	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 01/2020
8	Peptides (Polypeptides)IBA 01/2022 - 01/2008
7	Spironolactone (Aldactone)FDA LinkGeneric 03/2022 - 12/2005
7	Pharmaceutical PreparationsIBA 01/2022 - 01/2017
7	LipidsIBA 01/2022 - 02/2015
7	aliskiren FDA Link 10/2013 - 10/2009
6	AldosteroneIBA 04/2022 - 12/2005
6	PotassiumIBA 01/2022 - 12/2005
5	empagliflozinIBA 06/2022 - 11/2019
5	Urokinase Plasminogen Activator ReceptorsIBA 01/2022 - 06/2016
5	SymportersIBA 01/2022 - 05/2019
5	Angiotensin IIIBA 12/2021 - 08/2002
5	Biological ProductsIBA 11/2021 - 11/2011
5	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2021 - 07/2010
5	Metformin (Glucophage)FDA LinkGeneric 08/2021 - 01/2008
5	Hemoglobins (Hemoglobin)IBA 01/2021 - 10/2004
5	C-Reactive ProteinIBA 01/2021 - 01/2013
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019 - 05/2003
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 09/2005
5	AdiponectinIBA 01/2016 - 08/2008
5	Vitamin D FDA LinkGeneric 10/2013 - 10/2010
5	Advanced Glycation End ProductsIBA 11/2011 - 12/2006
4	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2020
4	Atrial Natriuretic Factor (ANF)IBA 10/2020 - 01/2017
4	CollagenIBA 10/2019 - 11/2010
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 09/2005
4	Connective Tissue Growth FactorIBA 01/2015 - 06/2005
4	Edetic Acid (EDTA)FDA Link 04/2008 - 08/2002
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2015
3	semaglutideIBA 01/2022 - 11/2020
3	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021 - 01/2017
3	candesartanIBA 01/2021 - 01/2016
3	Glucagon-Like Peptide-1 ReceptorIBA 01/2021 - 07/2015
3	Triglycerides (Triacylglycerol)IBA 10/2020 - 01/2016
3	bardoxolone methylIBA 10/2019 - 03/2013
3	N 30IBA 01/2019 - 11/2009
3	Lipocalin-2IBA 11/2018 - 01/2011
3	ReninIBA 10/2013 - 11/2008
3	Fatty Acid-Binding ProteinsIBA 05/2011 - 09/2009
2	Immunoglobulins (Immunoglobulin)IBA 06/2022 - 01/2021

Therapy/Procedure

37	Therapeutics 06/2022 - 03/2004
10	Glycemic Control 07/2022 - 12/2006
4	Transplantation 01/2022 - 09/2004
3	Kidney Transplantation 12/2021 - 09/2012